NASDAQ:CDTX
Cidara Therapeutics Stock News
$12.63
-0.370 (-2.85%)
At Close: Apr 26, 2024
Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
01:09pm, Saturday, 02'nd May 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
SAN DIEGO, April 28, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of.
Analysts Offer Insights on Healthcare Companies: Interpace Diagnostics Group (IDXG) and Principia Biopharma (PRNB)
02:22pm, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Interpace Diagnostics Group (IDXG) and Principia Biopharma
Oppenheimer Keeps Their Buy Rating on Athenex (ATNX)
09:57pm, Wednesday, 22'nd Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's shares
Oppenheimer Keeps Their Buy Rating on Athenex (ATNX)
09:57pm, Wednesday, 22'nd Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer assigned a Buy rating to Exact Sciences (EXAS), with a price target of $115.00. The
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday,
Kevin DeGeeter
from Oppenheimer assigned a
Buy
rating to Exact Sciences (
EXAS
–
Research Report
), with a price target of
$115.00
. The company’s shares closed las
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Vascular Biogenics (VBLT)
03:11am, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Vascular Biogenics (VBLT) with bullish
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Vascular Biogenics (NASDAQ: VBLT)
03:11am, Friday, 17'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB
Analysts Offer Insights on Healthcare Companies: Staar Surgical Company (STAA), Planet 13 Holdings (OtherPLNHF) and PolarityTE (PTE)
10:17am, Tuesday, 14'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (STAA), Planet 13 Holdings (PLNHF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (
STAA
–
Research Report
), Planet 13 Holdings (
PLNHF
–
Research Report
) a
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's shares
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Audentes Therapeutics (NASDAQ:BOLD)
09:14am, Thursday, 09'th Apr 2020
Audentes Therapeutics (NASDAQ:BOLD) and Cidara Therapeutics (NASDAQ:CDTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of t
Novavax (NVAX) Received its Third Buy in a Row
01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received another Buy, this time
